Anbio Biotechnology
NASDAQ:NNNN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Braskem SA
NYSE:BAK
|
BR |
Anbio Biotechnology
Other Items
Anbio Biotechnology
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Anbio Biotechnology
NASDAQ:NNNN
|
Other Items
-4.2m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Other Items
-€1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-96%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Other Items
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Other Items
€211.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Other Items
-€16.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
19%
|
|
|
Formycon AG
XETRA:FYB
|
Other Items
€28.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
228%
|
|
Anbio Biotechnology
Glance View
Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.
See Also
What is Anbio Biotechnology's Other Items?
Other Items
-4.2m
Based on the financial report for Dec 31, 2025, Anbio Biotechnology's Other Items amounts to -4.2m .
What is Anbio Biotechnology's Other Items growth rate?
Other Items CAGR 3Y
-40%
The average annual Other Items growth rates for Anbio Biotechnology have been -40% over the past three years .